Compare ANIK & PFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANIK | PFO |
|---|---|---|
| Founded | 1983 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.5M | 123.3M |
| IPO Year | 1993 | N/A |
| Metric | ANIK | PFO |
|---|---|---|
| Price | $9.45 | $9.38 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 170.5K | 31.8K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $112,806,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.79 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 30.55 | N/A |
| 52 Week Low | $7.87 | $6.90 |
| 52 Week High | $18.37 | $8.51 |
| Indicator | ANIK | PFO |
|---|---|---|
| Relative Strength Index (RSI) | 44.48 | 39.64 |
| Support Level | $9.36 | $9.38 |
| Resistance Level | $9.82 | $9.47 |
| Average True Range (ATR) | 0.21 | 0.09 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 15.22 | 27.91 |
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.